<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/css" href="https://imcjms.com/assets/rss.css" ?><rss version="2.0">
<channel>
    <title>IMC Journal of Medical Science</title>
    <link>https://imcjms.com</link>
    <description>Ibrahim Medical College Journal of Medical Science</description>

                        <item>
                <title><![CDATA[Brown Adipose Tissue - role in metabolic disorders]]></title>

                                    <author><![CDATA[Tahniyah Haq]]></author>
                                    <author><![CDATA[Frank Joseph Ong]]></author>
                                    <author><![CDATA[Sarah Kanji]]></author>
                
                <link data-url="https://imcjms.com/registration/journal_full_text/307">
    https://imcjms.com/registration/journal_full_text/307
</link>
                <pubDate>Sun, 25 Nov 2018 09:34:47 +0000</pubDate>
                <category><![CDATA[Review]]></category>
                <comments><![CDATA[IMC J Med Sci 2019; 13(1): 002]]></comments>
                <description>Abstract
Brown adipose
tissue, a thermogenic organ, previously thought to be present in only small
mammals and children has recently been identified in adult humans. Located
primarily in the supraclavicular and cervical area, it produces heat by
uncoupling oxidative phosphorylation due to the unique presence of uncoupling
protein 1 by a process called nonshivering thermogenesis. BAT activity depends
on many factors including age, sex, adiposity and outdoor temperature. Positron-emission tomography using 18F-fluorodeoxyglucose and computed tomography (18F-FDG PET–CT), magnetic resonance imaging (MRI) and
thermal imaging (IRT) are among several methods used to detect BAT in humans. The
importance of BAT is due to its role in whole body energy expenditure and fuel
metabolism. Thus it is postulated that it may be useful in the treatment of
metabolic diseases. However, there are still many unanswered questions to the
clinical usefulness of this novel tissue.
IMC J Med Sci
2019; 13(1): 002. EPub date: 03 February 2019.&amp;nbsp;DOI: https://doi.org/10.3329/imcjms.v13i1.42049  
Address for Correspondence: Dr. Tahniyah Haq, Assistant Professor, Department of
Endocrinology, Room 1620, 15th Floor, Block D, Bangabandhu Sheikh Mujib Medical
University, Shahbag, Dhaka, Bangladesh. Tel phone: 01677791735, email tahniyah81@gmail.com
&amp;nbsp;
Introduction
The rediscovery of functional brown adipose tissue (BAT) in
adult humans has generated interest in its potential as a therapeutic target to
improve metabolic health. BATis a thermogenic
organ located primarily in the supraclavicular area in adult humans. Smaller
deposits are also located in the paravertebral, perinephric and mediastinal
areas [1-4]. They possess uncoupling protein 1 (UCP-1) which acts as an
alternate proton channel through which hydrogen ions travel down the
electrochemical gradient, bypassing adenosine triphosphate (ATP) synthase and
dissipating energy as heat [5,6]. This process is called nonshivering
thermogenesis and is activated by cold and regulated by the sympathetic nervous
system [6,7]. Several studies have demonstrated that this
thermometabolic organ contributes to whole body energy expenditure [8-11] and
plays a role in glucose [11] as well as lipid metabolism [12]. There is ongoing
research to explore the role of BAT in diseases such as type 2 diabetes
mellitus, dyslipidaemia and nonalcoholic fatty liver disease. This review aims to highlight the morphology, location,
mechanism of action, detection and clinical usefulness of BAT.
&amp;nbsp;
Morphology
BAT is richly
vascularized and densely innervated by terminal fibres of the sympathetic
nervous system. It is characterized by polygonal cells with a central nucleus
and multiple, small vacuoles that store triglycerides (i.e. multilocular lipid
droplets). They are characteristically rich in large, spherical UCP-1
containing mitochondria. UCP-1 is uniquely expressed in the inner mitochondrial
membrane and is essential in the uncoupling of mitochondrial oxidative
phosphorylation [5]. 
&amp;nbsp;
Location and amount of BAT
BAT is
strategically located around major blood vessels to ensure adequate delivery of
substrates and effective dissipation of heat throughout the body [13]. Infants
and children have a considerable amount of active BAT which gradually regresses
with age, especially after puberty [14]. In infants, BAT consists of around
1-5% of their body weight [15] and is predominantly found in the interscapular
region. Retrospective studies under non-cold stimulated conditions have found
that 18F-fluorodeoxyglucose (18F-FDG)
uptake is present in 6.8-8.5% of
adults [1,16,17]. Out of these adults with detectable BAT activity, 18F-FDG uptake
is most commonly observed in the supraclavicular and cervical area (94.2%),
paravertebral area (61.6%), mediastinal/para-aortic (28%) and perirenal areas
(20.1%) [17]. Histological examination of tissue from the supraclavicular
region has confirmed the presence of BAT [1-4,8,16,17].
The estimated amount of active BAT
found in adult humans ranges from 4 to more than 1500 ml [18].
&amp;nbsp;
As noted
earlier, BAT is characterized by an abundance of UCP-1 containing mitochondria.
UCP-1, a six-domain transmembrane
protein, is central to the production of heat by nonshivering
thermogenesis. The expression
of UCP-1 can be enhanced by adrenergic stimulation and peroxisome
proliferator-activated receptor-γ (PPARγ) agonists [6]. Factors that can
increase the metabolic activity of BAT include the use of sympathomimetics, β adrenergic
agonists and cold exposure [6,7,19-21,25]. During BAT activation, there is
upregulation of UCP-1, which allows protons to travel down the electrochemical
gradient while bypassing the ATP synthase. As a result of this uncoupling of oxidative
phosphorylation, ATP is not synthesized and energy is dissipated as heat. With
less ATP production, there is no negative feedback inhibition of the
respiratory chain, producing a futile cycle [6] (Figure 1).
&amp;nbsp;
&amp;nbsp;
In addition to
the cooling protocol, the prevalence of BAT also depends on age, sex, adiposity
and outdoor temperature [17]. Age is an independent negative predictor of BAT
activity and mass, with BAT being more prevalent in younger individuals
[2,10,16,17,22,23]. However, the cause of this age-dependent decline in BAT is
currently unknown, but changes in sex and thyroid hormones as well as the
activity of the sympathetic nervous system associated with increasing age have
been speculated to be contributing factors [24]. Females have been observed to have
more BAT activity and mass compared to males in some studies [16,17,22] but not
all studies [23,25,26]. The difference in the prevalence of BAT between males
and females may be due to the different effects of sex hormones on BAT activity
[22] and the fact that females start to shiver at a higher temperature compared
to males [27]. Body mass index (BMI), central obesity, body fat percentage and
visceral fat are consistently lower in people with detectable BAT activity
[2,10,16,23,28,29]. BMI is not only negatively correlated with BAT, but is also
an independent predictor [1,2,16-17,28]. Whether increased BAT activity results
in a lower BMI or vice versa is still not known. Nahon and colleagues reported
that larger individuals with higher lean mass require exposure to lower
temperatures to activate cold-induced thermogenesis due to higher basal heat
generation in this population. As such, studies investigating the relationship
between BAT and adiposity should consider body size, composition and energy
expenditure when designing cold-induced thermogenesis studies [30]. BAT is more
likely to be detected during the winter compared to summer [1,2,31]. In
addition, BAT activity and mass is inversely related with outdoor temperature
at the time [1] or day [17,32] of the scan.These
studies show that lower outdoor temperature is associated with increased BAT
prevalence, volume and activity.
Multiple imaging modalities have
been utilized to characterize and differentiate BAT from surrounding tissues based
on its unique anatomical and functional properties. These techniques include 18F-FDG PET-CT, magnetic resonance imaging (MRI), infrared
thermography (IRT) and autonomous temperature sensors (i.e. iButtons). A
detailed review outlining recent advances in BAT detection has recently been
published by our group and therefore will only be briefly discussed [33]. 18F-FDG PET-CT is the current reference standard in the
detection of BAT. This modality measures the uptake of a glucose analogue (i.e.
18F-FDG)
that is taken up by BAT but is not metabolized [34]. Moreover, PET-CT has been
instrumental in advancing our knowledge in the identification, location and
nature of BAT [1-3,8,16,17]. However, a major limitation of PET-CT is the
significant and unnecessary exposure to ionizing radiation precluding its use
in large cohorts and in children [35]. Thus, alternative modalities including
MRI have been utilized in the detection of BAT. The use of this technique is
dependent on the morphological differences between BAT and surrounding tissues
resulting in unique MR signatures which can be measured using fat-fraction (FF)
and T2* relaxation (T2*). Generally, BAT is characterized by smaller FF and T2*
values due to its lower lipid content, greater vascularization and abundance of
iron-rich mitochondria. In addition, both FF and T2* can also be used to
measure BAT metabolic activity as reductions in these parameters have been
associated with 18F-FDG
uptake [36]. Imaging modalities that measure changes in skin temperature including
IRT and autonomous temperature sensors have been used to detect BAT [13]. These techniques rely on the
heat produced by BAT via non-shivering thermogenesis in the overlying skin when
activated. However, the use of these modalities in measuring BAT activity is
often confounded by skin thickness, increased blood flow and muscle activity
upon cold exposure. As such, further investigation is warranted before these
modalities can be widely adapted in the measurement of BAT. Other emerging modalities are currently being
developed to measure BAT. However, these methods are of limited availability, expensive
and still in their infancy. Examples include detection of BAT using
hyperpolarized MRI [37,38], contrast ultrasound, near-infrared fluorescence
imaging [39] and near-infrared time-resolved spectroscopy.
2.&amp;nbsp;&amp;nbsp; Saito M, Okmatsu-Ogura Y, Matsushita M, Watanabe K, Yoneshiro T,
Nio-Kobayashi J, et al. High incidence of metabolically active brown adipose tissue in
healthy adult humans: effects of cold exposure and adiposity. Diabetes. 2009; 58: 1526–1531.
4.&amp;nbsp;&amp;nbsp; Zingaretti MO,
Crosta F, Vitali A, Guerrieri M, Frontini A,
Cannon B, et al. The presence
of UCP-1 demonstrates that metabolically active adipose tissue in the neck of
adult humans truly represents brown adipose tissue. FASEB Journal. 2009; 23:
3113–3120.
6.&amp;nbsp;&amp;nbsp; Richard D,
Carpentier AC, Dore´ G, Ouellet V, Picard F. Determinants of brown adipocyte
development and thermogenesis. Int J Obes.
2010; 34: S59–S66.
8.&amp;nbsp;&amp;nbsp; Van Marken Lichtenbelt WD, Vanhommerig
JW, Smulders NM, Drossaerts J M, Kemerink GJ, Bouvy ND, et al. Cold activated brownadipose tissue in healthy men. N Engl J Med. 2009; 360: 1500–1508.
10.&amp;nbsp; Yoneshiro T,
Aita S, Matsushita M, Kameya T, Nakada K, Kawai Y, et al. Brown Adipose Tissue, Whole-Body Energy Expenditure, and
Thermogenesis in Healthy Adult Men. Obesity. 2011; 19: 13–16.

14.&amp;nbsp; Virtanen KA,
Nuutila P. Brown adipose tissue in humans. Nutr
Metab. 2011; 22: 49–54.
16.&amp;nbsp; Lee P,
Greenfield JR, Ho KKY, Fulham MJ. A critical appraisal of the prevalence and
metabolic significance of brown adipose tissue in adult humans. Am J Physiol Endocrinol Metab. 2010; 299(4): E601–E606.
18.&amp;nbsp; Blondin DP,
Labbé SM, Turcotte EE, Haman F, Richard D, Carpentier AC. A critical appraisal
of brown adipose tissue metabolism in humans. Clin Lipidol. 2015; 10:
259–280.
22.&amp;nbsp; Pfannenberg C, Werner MK, Ripkens S, Stef I,
Deckert A, Schmadl M, et al. Impact of
age on the relationships of brown adipose tissue with sex and adiposity in
humans. Diabetes. 2010; 59: 1789–1793.
24.&amp;nbsp; Lecoultre V, Ravussin E. Brown adipose tissue and
aging. Cur Opin Clin Nutr Metab Care.
2011; 14: 1–6.
25.&amp;nbsp; Cypess AM,
Chen YC, Sze C, Wang K, English J, Chan O, et
al. Cold but not sympathomimeticsactivates human brown adipose tissue in vivo. Proc NatlAcad Sci USA. 2012; 109(25): 10001–10005.
27.&amp;nbsp; Van der Lans AAJJ, Wierts R, Vosselman MJ,
Schrauwen P, Brans B, van Marken Lichtenbelt WD. Cold-activated brown
adipose tissue in human adults: methodological issues. Am J Physiol Regul Integr Comp Physiol. 2014; 307: R103–R113.
29.&amp;nbsp; Green AL,
Bagci U, Hussein S, Kelly PV, Muzaffar R, Neuschwander-Tetri BA, et al. Brown adipose tissue detected by
PET/CT imaging is associated with less central obesity. Nucl Med Commun. 2017; 38(7):
629–635.
31.&amp;nbsp; Cohade C,
Mourtzikos KA, Wahl RL. &#039;&#039;USA-Fat&#039;&#039;:
Prevalence Is Related to Ambient Outdoor Temperature--Evaluation with 18F-FDG PET/CT. The Journal of Nuclear Medicine. 2003; 44: 1267–1270.
35.&amp;nbsp; Cypess AM,
Haft CR, Laughlin MR, Hu HH. Brown fat in humans: Consensus points and
experimental guidelines. Cell Metab.
2014; 20: 408–415.
37.&amp;nbsp; Branca RT,
White C, Zhang L. Detection of brown fat mass and activity by hyperpolarized
xenon MR. Proceedings of the 21st Annual
Meeting ISMRM, Salt Lake City, UT. 2013; 404.
39.&amp;nbsp; Azhdarinia
A, Daquinag AC, Tseng C, Ghosh SC, Ghosh P, Amaya-Manzanares F, et al. A
peptide probe for targeted brown adipose tissue imaging. Nat. Commu. 2013; 4: 2472.
41.&amp;nbsp; Iwen KA,
Backhaus J, Cassens M, Walti M, Hedesan OC, Merkel M, et al. Cold-induced brown
adipose tissue activity alters plasma fatty acids and improves glucose
metabolism in men. J Clin Endocrinol
Metab. 2017; 102(11): 4226-4234.
43.&amp;nbsp; Stefan N,
Pfannenberg C, Häring HU. The Importance of Brown Adipose Tissue. N Engl J Med. 2009; 361(4): 416-417.
45.&amp;nbsp; Lee P, Smith
S, Linderman J, et al. Temperature-acclimated
brown adipose tissue modulates insulin sensitivity in humans. Diabetes. 2014; 63: 3686–369.
47.&amp;nbsp; Liu X, Wang
S, You Y, Meng M, Zheng Z, Dong M, et al.
Brown adipose tissue transplantation reverses obesity in ob/ob mice. Endocrinology.
2015; 156: 2461–2469.
</description>

            </item>
            
    <copyright>2026 Ibrahim Medical College. All rights reserved.</copyright>
</channel>
</rss>
